Related references
Note: Only part of the references are listed.2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022
DIABETES CARE (2022)
Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis
Daniele Pastori et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
Kenneth Cusi et al.
ENDOCRINE PRACTICE (2022)
The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study
Matina Kouvari et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
World Heart Federation Cholesterol Roadmap 2022
Kausik K. Ray et al.
GLOBAL HEART (2022)
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani et al.
GUT (2021)
Recent advances in nonalcoholic fatty liver disease metabolomics
Hwi Young Kim
CLINICAL AND MOLECULAR HEPATOLOGY (2021)
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Hokyou Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher et al.
DIABETES & METABOLISM (2021)
3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea
Goh Eun Chung et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Association of Statin Therapy Initiation With Diabetes Progression A Retrospective Matched-Cohort Study
Ishak A. Mansi et al.
JAMA INTERNAL MEDICINE (2021)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes
Carla Busquets-Cortes et al.
BMJ OPEN (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Mohammed Eslam et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Metabolically healthy obesity and risk of incident type 2 diabetes in 1077 statin-treated individuals: A six-year retrospective study
Fotios Barkas et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
Helen Jarvis et al.
PLOS MEDICINE (2020)
Untitled
Fotios Barkas et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity
Fotios Barkas et al.
JOURNAL OF CARDIOLOGY (2019)
Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids
Eline H. van den Berg et al.
NUTRIENTS (2019)
Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study
Olubunmi Olujimisola Olubamwo et al.
BMJ OPEN (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
Christina C. Lindenmeyer et al.
CLINICS IN LIVER DISEASE (2018)
Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study
Josep Franch-Nadal et al.
PLOS ONE (2018)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Drug-Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism
U. Anyanwagu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials)
Payal Kohli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome
Fotios Barkas et al.
ATHEROSCLEROSIS (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
DIABETOLOGIA (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Statin therapy with or without ezetimibe and the progression to diabetes
Fotios Barkas et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
Xiaolin Huang et al.
MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lipid Target Achievement Among Patients With Very High and High Cardiovascular Risk in a Lipid Clinic
Fotios Barkas et al.
ANGIOLOGY (2015)
How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic
Fotios Barkas et al.
CURRENT MEDICAL RESEARCH AND OPINION (2015)
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2012)
Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin Results From 3 Large Randomized Clinical Trials
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Share Paper
